Pharmapack 2021, leading hub for stakeholders across all parts of the pharmaceutical packaging and drug delivery supply chain, with over 5,300 attendees and quite 400 exhibitors from quite 75 countries expected to be present ,will be held at the Porte De Versailles in Paris from January 27-28, 2021.
In an in-depth review of the market and having evaluated the collective developments from this year’s Pharmapack event, Gregor Anderson, MD of Pharmacentric Solutions said “I am really encouraged by the huge strides we’ve made this year. As an industry, we are not any longer paying hypocrisy to sustainability and wherein once there may need just been one dedicated employee, there are now entire teams watching improving methods and exploring life-cycle impact.”
one among the large differences identified is that the increased sharing across the industry and the way actively involved the whole supply chain is within the discussion. Both the suppliers of packaging and devices are working more closely with big pharma and this is often resulting in accelerated development.
The next stage is interoperability, as for the industry to be ready to truly meet sustainability goals it’ll got to stop applying bespoke solutions company by company. consistent with Anderson meaning “bringing material suppliers into the talk and potentially working across the industry with big pharma, device and packaging suppliers together. in order that we will deliver the economies of scale needed to incentivize the event of more environmentally sustainable materials. It’s a couple of years away yet, but standardised use of materials industry-wide could make a huge improvement to the choices we’ve . And then, we’d like to increase this to how we are setting-up the networks to recycle these post use.”
Another big improvement is exploring how the patient reacts to new innovations and their behavior. for instance , it’s been overlooked in developments until recently, but reducing the misuse of medicines might be another massive stride forward. “It’s widely accepted that up to 50% of medicines don’t get used correctly by patients, ultimately resulting in their waste or maybe unnecessary alternatives then being tried. Anything the industry can do to enhance adherence will automatically be a really sustainable approach. But at an equivalent time, we don’t want to be giving patients solutions that are too complex with large numbers of various devices and interfaces,” added Anderson.
The most encouraging aspect is that whilst no single solution are going to be the solution , there’s active sharing across the industry, with even big pharma presenting data and case studies on how they need implemented improvements. To be fully sustainable, it’s getting to take the industry to collaborate across variety of areas. “Overall, i’m very encouraged by what I even have seen this year. you simply need to check out the amount of dedicated sustainability presentations at Pharmapack and therefore the number of latest improvements present. I actually see an enormous role for Pharmapack within the future in providing the industry platforms to debate initiatives and share ideas”, concluded Anderson.
“We cannot escape the broader problems with society at the instant , but I also think it’s important that we continue momentum and still promote the good sustainability strides the industry has within the last year. In fact, it’s getting to be a way bigger a part of what do within the future at Pharmapack, in helping deliver platforms to coalesce new ideas around. we would like the industry to ascertain the event as a source of latest debate, new analysis and new thinking – and that we will publish a drug delivery and device summary paper later within the year,” commented Silvia Forroova, brand director at Pharmapack Europe.
The full podcast with Gregor Anderson on everything from replacing PVC in France to training doctors on devices, and therefore the role the patient are often play in sustainability is out there on CPhI’s new insights platform.